Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Clinical trial NCT03016377 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03016377
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Immune System Diseases Immunoproliferative Disorders

Start date: 2012-03-22
Primary completion: 2025-09-12
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.